Provided by Tiger Trade Technology Pte. Ltd.

Alexander's

242.37
-3.1900-1.30%
Pre-market: 242.36-0.01000.00%08:00 EDT
Volume:41.48K
Turnover:10.16M
Market Cap:1.24B
PE:44.07
High:250.65
Open:249.60
Low:240.59
Close:245.56
52wk High:260.84
52wk Low:189.05
Shares:5.11M
Float Shares:2.13M
Volume Ratio:0.50
T/O Rate:1.95%
Dividend:18.01
Dividend Rate:7.43%
EPS(TTM):5.50
EPS(LYR):5.50
ROE:19.74%
ROA:3.32%
PB:11.34
PE(LYR):44.10

Loading ...

Earnings Flash (ALX) Alexander's Posts Q3 Non-GAAP FFO $2.91 a Share

MT Newswires Live
·
Nov 03, 2025

Evaluating Alexander's (ALX): Is the Current Valuation Justified After Recent Price Swings?

Simply Wall St.
·
Nov 01, 2025

Alexander's Inc expected to post a share - Earnings Preview

Reuters
·
Oct 31, 2025

ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting

GlobeNewswire
·
Oct 30, 2025

Alexander's Keeps Quarterly Dividend at $4.50 a Share, Payable Nov. 28 to Shareholders of Record Nov. 10

MT Newswires Live
·
Oct 30, 2025

Press Release: Alexander's Declares Quarterly $4.50 Dividend on Common Shares

Dow Jones
·
Oct 30, 2025

ALX presents preclinical data, Phase 1 trial-in-progress for ALX2004

TIPRANKS
·
Oct 24, 2025

ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference

GlobeNewswire
·
Oct 24, 2025

Did Chicago Skyway’s Bond Issuance Just Shift Atlas Arteria’s (ASX:ALX) Investment Narrative?

Simply Wall St.
·
Oct 22, 2025

Alexander’s Announces Third Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call

GlobeNewswire
·
Oct 22, 2025

Will Atlas Arteria’s (ASX:ALX) Debt Strategy Reshape Its Capital Flexibility?

Simply Wall St.
·
Oct 15, 2025

ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire
·
Oct 03, 2025

Woodlands Financial Services Company Appoints Jay B. Alexander as Chairman of the Board

Reuters
·
Sep 26, 2025

ALX Oncology CEO Makes Bold Stock Purchase!

TIPRANKS
·
Sep 19, 2025

ALX Oncology Announces Management Changes Amidst Nasdaq Compliance

TIPRANKS
·
Sep 12, 2025

ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer

GlobeNewswire
·
Sep 12, 2025